These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dendritic cell subsets as vectors and targets for improved cancer therapy. Palucka K; Ueno H; Roberts L; Fay J; Banchereau J Curr Top Microbiol Immunol; 2011; 344():173-92. PubMed ID: 20490776 [TBL] [Abstract][Full Text] [Related]
3. Dendritic cells: are they clinically relevant? Palucka K; Ueno H; Roberts L; Fay J; Banchereau J Cancer J; 2010; 16(4):318-24. PubMed ID: 20693842 [TBL] [Abstract][Full Text] [Related]
4. Building on dendritic cell subsets to improve cancer vaccines. Palucka K; Ueno H; Zurawski G; Fay J; Banchereau J Curr Opin Immunol; 2010 Apr; 22(2):258-63. PubMed ID: 20226644 [TBL] [Abstract][Full Text] [Related]
5. The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines. López M; Aguilera R; Pérez C; Mendoza-Naranjo A; Pereda C; Ramirez M; Ferrada C; Aguillón JC; Salazar-Onfray F Immunobiology; 2006; 211(1-2):127-36. PubMed ID: 16446177 [TBL] [Abstract][Full Text] [Related]
6. Harnessing dendritic cells to generate cancer vaccines. Palucka K; Ueno H; Fay J; Banchereau J Ann N Y Acad Sci; 2009 Sep; 1174():88-98. PubMed ID: 19769741 [TBL] [Abstract][Full Text] [Related]
7. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies. Galati D; Zanotta S Cytotherapy; 2018 Nov; 20(11):1309-1323. PubMed ID: 30360963 [TBL] [Abstract][Full Text] [Related]
14. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Conroy H; Marshall NA; Mills KH Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598 [TBL] [Abstract][Full Text] [Related]
15. Guiding the "misguided" - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours. Huang FP; Chen YX; To CK Eur J Immunol; 2011 Jan; 41(1):18-25. PubMed ID: 21182072 [TBL] [Abstract][Full Text] [Related]